Metropolis Healthcare Shares Gain 4%; Reports Higher Q4 FY26 Profit and Revenue Growth

Metropolis Healthcare Ltd reported improved financial performance for the fourth quarter, supported by growth in revenue, patient volumes and operating margins. The diagnostics company recorded stronger business momentum across its consumer-focused operations, preventive testing services and digital engagement initiatives. 

Q4 Profit Rises on Operational Growth

Metropolis Healthcare reported a consolidated net profit of ₹51 crore for the quarter ended March 2026, compared with ₹29 crore in the corresponding quarter of the previous year. The increase represented year-on-year growth of approximately 131.8%.

The company’s revenue from operations rose 23% year-on-year to ₹425 crore, up from ₹345 crore in the same quarter last year. Growth was supported by increased testing demand, wider market reach and improved engagement with clinicians and healthcare providers.

EBITDA and Margin Expansion

Earnings before interest, tax, depreciation and amortisation (EBITDA) increased 73.4% year-on-year to ₹108 crore from ₹62.3 crore reported in the corresponding quarter last year.

EBITDA margins improved to 25.4%, compared with 18% a year earlier. The margin expansion reflected operational efficiencies, improved service mix and stronger contribution from specialised and preventive testing segments.

Growth in Patient and Test Volumes

The diagnostics chain reported an 11% year-on-year increase in patient volumes during the quarter. Test volumes also grew 14% year-on-year, indicating sustained demand across diagnostic categories.

Management attributed the performance to:

• Increased preventive healthcare awareness
• Expansion in specialised testing services
• Wider market penetration5
• Stronger clinician engagement
• Improved customer outreach initiatives

Dividend Declaration

Alongside the quarterly earnings announcement, the company also declared a dividend, reflecting continued focus on shareholder returns while maintaining operational expansion initiatives.

Read More: Rupee Hits Record Low Of 95.80 Despite Duty Hike on Gold Imports.

Metropolis Healthcare Share Price Performance

As of 14 May 2026 at 09:34 AM, shares of Metropolis Healthcare were trading at ₹568.35 on the NSE, up ₹20.35 or 3.71% from the previous close of ₹548.00.

Conclusion

Metropolis Healthcare’s fourth-quarter results reflected growth across revenue, profitability and operational metrics. Higher patient volumes, increased preventive testing demand and stronger digital engagement contributed to the company’s performance during the quarter.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks. Read all related documents carefully before investing.